148 related articles for article (PubMed ID: 3839559)
1. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
Marie PJ; Hott M; Garba MT
Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
Marie PJ; Travers R
Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
Marie PJ; Hott M; Garba MT
Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic study of the effect of 1,25-dihydroxyvitamin D3 on bone matrix synthesis in vitamin D replete rats.
Hock JM; Kream BE; Raisz LG
Calcif Tissue Int; 1982 Jul; 34(4):347-51. PubMed ID: 6814724
[TBL] [Abstract][Full Text] [Related]
5. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.
Garba MT; Marie PJ
Calcif Tissue Int; 1986 May; 38(5):296-302. PubMed ID: 3087604
[TBL] [Abstract][Full Text] [Related]
6. Bone histomorphometry in 1,25(OH)2D3- and vitamin D3-treated aged laying hens.
Newbrey JW; Truitt ST; Roland DA; Frost TJ; Untawale GG
Avian Dis; 1992; 36(3):700-6. PubMed ID: 1329713
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
Marie PJ; Hott M; Garba MT
Bone; 1985; 6(3):193-200. PubMed ID: 4027097
[TBL] [Abstract][Full Text] [Related]
8. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
Gallagher JA; Beneton M; Harvey L; Lawson DE
Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
[TBL] [Abstract][Full Text] [Related]
9. Skeletal resistance to 1,25-dihydroxyvitamin D3 in osteopetrotic rats.
Safadi FF; Hermey DC; Popoff SN; Seifert MF
Endocrine; 1999 Dec; 11(3):309-19. PubMed ID: 10786828
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO).
Lempert UG; Minne HW; Albrecht B; Scharla SH; Matthes F; Ziegler R
Bone Miner; 1989 Sep; 7(2):149-58. PubMed ID: 2804450
[TBL] [Abstract][Full Text] [Related]
11. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
Epstein S; Schlosberg M; Fallon M; Thomas S; Movsowitz C; Ismail F
Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
Hock JM; Gunness-Hey M; Poser J; Olson H; Bell NH; Raisz LG
Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
[TBL] [Abstract][Full Text] [Related]
13. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
Goodman WG; Baylink DJ; Sherrard DJ
Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
[TBL] [Abstract][Full Text] [Related]
14. Osteoinduction by implants of demineralized allogeneic bone matrix is diminished in vitamin D-deficient rats.
Vandersteenhoven JJ; DeLustro FA; Bell NH; Turner RT
Calcif Tissue Int; 1988 Jan; 42(1):39-45. PubMed ID: 3129166
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
[TBL] [Abstract][Full Text] [Related]
16. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
[TBL] [Abstract][Full Text] [Related]
18. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
19. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles.
Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
Endocrinology; 2006 Oct; 147(10):4801-10. PubMed ID: 16857747
[TBL] [Abstract][Full Text] [Related]
20. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
Boiskin I; Epstein S; Ismail F; Fallon MD; Levy W
Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
